Further studies on an inhibitor of viral activity appearing in infected cell cultures and its role in chronic viral infections.
about
Factors influencing the occurrence of illness during naturally acquired polimyelitis virus infectionsInterferon: a changing pictureResponse of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferonMeasles virus and its associated diseases.Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas.Interferon system in cells from human tumors and from persons predisposed to cancer.Comparative production of interferon by human fetal, neonatal, and maternal cellsINTERFERON PRODUCTION INDUCED BY STATOLONRole of interferon in murine lactic dehydrogenase virus infection, in vivo and in vitro.PERSISTENT POLIOVIRAL INFECTION OF INTACT HUMAN AMNIOTIC MEMBRANE WITHOUT APPARENT CYTOPATHIC EFFECT.Variation in ability of measles virus plaque progeny to induce interferon.VARIATIONS IN THE ABILITIES OF SEVERAL LINES OF L CELLS TO PRODUCE AND TO BE AFFECTED BY INTERFERON.Plaque Development and Induction of Interferon Synthesis by RMC Poliovirus.Antiviral action of mouse interferon in heterologous cells.IDENTIFICATION AND "INDUCTION" OF INTERFERON.Cellular resistance to viral infection, with particular reference to endogenous interferonThe mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by Coxsackie B3 virus and effect on superinfection.The role of interferon in vaccinia virus infection of mouse embryo tissue culture.A lipogenic toxin released through the interaction of a new cytopathic agent (lipovirus) and cultured human cells.The biological, immunological, and physicochemical characterization of a transmissible agent capable of inducing DNA and thymine degradation in cultured human cellsImmunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography.THE SPARING EFFECT OF RMC POLIOVIRUS ON PRIMARY AMNION CELL CULTURES.Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complexCharacterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus.Relative sensitivities of viruses to different species of interferonInterferon production by human cells in vitroGrowth characteristics of a herpesvirus of turkeysPRODUCTION OF AN INTERFERON BY L CELLS INFECTED WITH WESTERN EQUINE ENCEPHALOMYELITIS VIRUS.SPECIFIC VIRAL INTERFERENCE IN HELA CELL CULTURES CHRONICALLY INFECTED WITH COXSACKIE B5 VIRUSInterferons and host resistance: with particular emphasis on induction by complexed polynucleotides.Inhibition of Herpesvirus hominis replication by human interferon.Multiplication of measles virus in cell cultures.Inhibition of herpes simplex virus strains isolated from herpetic keratitis by polyinosinic acid-polycytidylic acid.An assay of interferon produced in rhesus monkey and calf kidney tissue cultures using bovine enterovirus M6 as challenge.MUTATION TO INCREASED VIRULENCE DURING CHRONIC INFECTION WITH SABIN LSC.2AB TYPE I POLIOVIRUS.The purification of interferon.Factors contributing to recovery from viral diseases.ROLE OF INTERFERON IN THE AUTOINTERFERENCE OF NEWCASTLE DISEASE VIRUS (NDV).High dose suppression of human anti-influenza A virus responses using T cell clones.Production of mouse interferon with high titers in a large-scale suspension culture system.
P2860
Q24562673-70C39443-21E0-4B5E-965D-BE3A33DED4F7Q27480942-1EF9D2BB-0993-441C-94D2-A7D316C36827Q33903703-027FE999-0019-4238-9251-24C04A048B8DQ34073606-6D481E39-D272-4887-BD15-794B4069D034Q34123702-A550B9D4-5706-4340-A56F-0B18C36CA02DQ34167951-3FA73A76-561D-4F3B-917E-22FB4B74BF42Q34170598-EF81DF5F-CB4B-43DA-AE61-A7B10E20747EQ34412733-348D07E6-4765-41A1-8E9F-C2FF0C48C70FQ34499397-CAE7619B-9164-443C-9522-114602CC6991Q34660417-11F7082A-8B8E-42AD-ABA5-B6710E7AEEB5Q35038946-249D520E-AD9C-4D61-8204-D214CC4E3DB1Q35162775-39E49A7D-C134-41A1-B273-B935767E289AQ35167109-E27B5D3B-1C66-4B5B-A26C-984B1342BF8DQ35174386-F4CC41B4-9ACC-4ABF-B798-81BC5A7F7F15Q35480634-F6CE066C-E8A6-409D-8D5D-D6EC6475B01CQ35544460-675D5E49-D970-4AED-95A4-C30A7969E5FEQ36265319-E26947A3-8121-4B01-A471-B6B4353279BDQ36265846-E2E19A6F-1086-492C-9332-132AC83F2863Q36265927-5BB71A2A-55D9-4941-B57C-0A4553246370Q36265949-C364131B-21E5-42E7-8EB4-BEBF18FFDAC5Q36352818-4B7DE2C4-A10E-43DB-A6BD-5DE4A56ACBE2Q36439436-5A2EF0DD-D138-4260-BC19-B6F56F99ADAEQ36467043-5246DC1C-E8E3-4C05-A8EA-9DC62C50A171Q36924474-2D3C3AFE-9D38-4414-93AF-F7FC4B4533FCQ37135472-4AD5D445-2BD5-4508-A77D-BA71EAFAF98AQ37250958-3D0663EF-2005-4810-B753-AC5F3070EBD5Q37251884-26DF2DE2-F112-4251-903D-A56FFAA37ECDQ37432667-84E0B487-8DF5-48CD-8533-5117ED740A5DQ37444206-51E3112A-269F-4963-B274-9233A3C48555Q39924192-A7124376-6BC6-4412-A9D0-A810AB154B80Q39937247-C5EB6FE6-966C-4CEB-A197-D0F4611FCBD1Q40032235-CF378E97-7B01-43E2-94C3-DE5FAB515ED9Q40082344-E5D1EAE1-2745-451E-9D9A-6F836C808F73Q40674750-A9BBC31B-4E98-41F9-8182-3A1CDB191598Q40678549-A439765A-63AC-4EB3-A128-D4168FF2CC1BQ42128783-5E40BD7A-965E-43ED-B35E-830A8BEC7C2CQ42229690-AE12F756-040C-4515-873C-CC626EB7CAC5Q45714501-15CF9D2A-48EC-454F-8626-C473051276ABQ45839354-9443FB76-599F-43A3-A516-2B6A47C026D6Q54140710-7A918294-77EB-4AFA-AFC3-04AB6917140D
P2860
Further studies on an inhibitor of viral activity appearing in infected cell cultures and its role in chronic viral infections.
description
1959 nî lūn-bûn
@nan
1959年の論文
@ja
1959年学术文章
@wuu
1959年学术文章
@zh-cn
1959年学术文章
@zh-hans
1959年学术文章
@zh-my
1959年学术文章
@zh-sg
1959年學術文章
@yue
1959年學術文章
@zh
1959年學術文章
@zh-hant
name
Further studies on an inhibito ...... e in chronic viral infections.
@en
Further studies on an inhibito ...... e in chronic viral infections.
@nl
type
label
Further studies on an inhibito ...... e in chronic viral infections.
@en
Further studies on an inhibito ...... e in chronic viral infections.
@nl
prefLabel
Further studies on an inhibito ...... e in chronic viral infections.
@en
Further studies on an inhibito ...... e in chronic viral infections.
@nl
P1433
P1476
Further studies on an inhibito ...... e in chronic viral infections.
@en
P304
P356
10.1016/0042-6822(59)90135-7
P407
P577
1959-11-01T00:00:00Z